What is my tumor's molecular profile and are there any targetable mutations
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
I'd be happy to help you understand your tumor's molecular profile and any targetable mutations! However, I don't see any [ID removed] test results, or pathology reports attached to your message.
To give you a meaningful educational interpretation, I'll need you to share:
Documents that would help:
- Pathology report (shows tumor type and biomarkers)
- Genomic testing results (like next-generation sequencing/NGS, panel testing, or specific mutation tests)
- Immunohistochemistry (IHC) results
- Fluorescence in situ hybridization (FISH) results
- Any molecular profiling reports from labs like Foundation Medicine, Guardant, or similar
Once you upload these, I can help explain:
- What specific mutations or biomarkers your tumor has
- Which mutations are "actionable" (meaning targeted drugs exist for them)
- How oncologists typically use this information to guide treatment decisions
- What questions to ask your care team about your specific results
In the meantime, here's what's generally helpful to know:
Modern cancer care increasingly relies on molecular profiling—testing your tumor's DNA to find specific mutations. According to NCCN Guidelines, many cancer types now have targeted therapies available for specific mutations (like EGFR in lung cancer, BRAF in melanoma, or HER2 in breast cancer).
Please share your test results, and I'll walk you through what they mean in plain language!
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Related Services
Services that may help with diagnosis for cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ